Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
40
EMA:19
NMPA:14
SFDA:7
Drug Approvals
Lenacapavir Sodium Injection
- Product Name
- 萨兰卡
- Approval Number
- 国药准字HJ20240170
- Approval Date
- Dec 25, 2024
NMPA
Sofosbuvir, Velpatasvir and Voxilaprevir tablets
- Product Name
- 沃士韦
- Approval Number
- 国药准字HJ20190061
- Approval Date
- Nov 12, 2024
NMPA
Bictegravir Sodium, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
- Product Name
- 必妥维
- Approval Number
- 国药准字HJ20190047
- Approval Date
- Apr 16, 2024
NMPA
Tenofovir alafenamide Fumarate Tablets
- Product Name
- 韦立得
- Approval Number
- 国药准字HJ20180060
- Approval Date
- Jul 13, 2023
NMPA
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅰ）
- Product Name
- 恩曲他滨丙酚替诺福韦片(Ⅰ)
- Approval Number
- 国药准字HJ20180066
- Approval Date
- Jun 19, 2023
NMPA
Ledipasvir and Sofosbuvir Tablets
- Product Name
- 夏帆宁
- Approval Number
- 国药准字HJ20180068
- Approval Date
- Jun 7, 2023
NMPA
Amphotericin B Liposome for Injection
- Product Name
- 注射用两性霉素B脂质体
- Approval Number
- 国药准字HJ20233123
- Approval Date
- Feb 28, 2023
NMPA
Elvitegravir, Cobicistat, Emtricitabine and Tenofovir Alafenamide Fumarate Tablets
- Product Name
- 捷扶康
- Approval Number
- 国药准字HJ20180043
- Approval Date
- Feb 14, 2023
NMPA
Sofosbuvir and velpatasvir tablets
- Product Name
- 丙通沙
- Approval Number
- 国药准字HJ20180024
- Approval Date
- Jan 4, 2023
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found